v3.26.1
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2026
Dec. 31, 2025
Subsidiary, Sale of Stock [Line Items]        
Common stock, shares authorized 200,000,000   200,000,000 200,000,000
Common stock, par value $ 0.000001   $ 0.000001 $ 0.000001
Perferred stock authorized 10,000,000   10,000,000 10,000,000
Preferred stock, par value $ 0.000001   $ 0.000001 $ 0.000001
Common stock, shares issued 24,013,577   24,013,577 23,245,203
Common stock, shares outstanding 24,013,577   24,013,577 23,245,203
Preferred stock, shares outstanding 0   0 0
Restricted stock issued, shares 0 50,000    
Restricted stock issued, value   $ 138,500    
A T M Agreement [Member]        
Subsidiary, Sale of Stock [Line Items]        
Stock issued new, shares     498,193  
Proceeds from sale of equity     $ 1,249,591  
Deferred offering costs $ 1,622   1,622  
Remaining borrowing capacity $ 98,700,000   $ 98,700,000  
Committed Equity Facility [Member]        
Subsidiary, Sale of Stock [Line Items]        
Stock issued new, shares     0